Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
暂无分享,去创建一个
M. Kattan | T. Wheeler | S. Shariat | C. Nguyen | K. Slawin | D. Spencer | E. Gottenger | Cuong Q. Nguyen | Weitao Song | John Andenoro
[1] H. Levin,et al. Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] M. Kattan,et al. Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M. Kattan,et al. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. , 2001, Urology.
[4] E. Bergstralh,et al. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. , 2001, Mayo Clinic proceedings.
[5] M. Kattan,et al. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] E. B. Butler,et al. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] D. Tindall,et al. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein. , 2000, Cancer research.
[8] M. Kattan,et al. The definition of biochemical failure in patients treated with definitive radiotherapy. , 2000, International journal of radiation oncology, biology, physics.
[9] M. Kattan,et al. Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy. , 2000, Urology.
[10] D. Chan,et al. Natural History of Progression After PSA Elevation Following Radical Prostatectomy , 1999 .
[11] D. Chopin,et al. Blood‐based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow‐up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy , 1999, International journal of cancer.
[12] K. Kaul,et al. Clinical and molecular followup after radical retropubic prostatectomy. , 1999, The Journal of urology.
[13] Higashihara,et al. Preoperative nested reverse transcription‐polymerase chain reaction for prostate specific membrane antigen predicts biochemical recurrence after radical prostatectomy , 1999, BJU international.
[14] D. Tindall,et al. Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases. , 1999, Urology.
[15] N. Oakley. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results , 1999 .
[16] J. Moul,et al. Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer. , 1999, Urology.
[17] V. Paradis,et al. Molecular expression of PSMA mRNA and protein in primary renal tumors , 1999, International journal of cancer.
[18] M. Kattan,et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. , 1998, Journal of the National Cancer Institute.
[19] Manjula.,et al. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage. , 1998, Cancer Research.
[20] W. Ellis,et al. The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer. , 1998, Journal of Urology.
[21] Katz Ae,et al. The role of reverse transcriptase-polymerase chain reaction for staging patients with clinically localized prostate cancer. , 1998 .
[22] E. Diamandis,et al. Frequency of expression of prostate-specific antigen mRNA in lung tumors. , 1997, American journal of clinical pathology.
[23] F. V. Lente,et al. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] K. Pantel,et al. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] M. Rubin,et al. Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase‐polymerase chain reaction assay in patients with early stage prostate carcinoma , 1997, Cancer.
[26] G G Klee,et al. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. , 1997, Urology.
[27] A. Partin,et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. , 1997, The Urologic clinics of North America.
[28] P. Lavagnini,et al. Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancer. , 1996, British Journal of Cancer.
[29] S. Loening,et al. Detection of PSA mRNA in blood by RT-PCR does not exclusively indicate prostatic tumor cells. , 1996, Clinical chemistry.
[30] M. Benson,et al. Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. , 1996, The Journal of urology.
[31] N. Vogelzang. Comprehensive Textbook of Genitourinary Oncology , 1996 .
[32] M. Hussain,et al. Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. , 1995, Cancer research.
[33] M. Benson,et al. Molecular Stating of Prostate Cancer. II. A Comparison of the Application of an Enhanced Reverse Transcriptase Polymerase Chain Reaction Assay for Prostate Specific Antigen Versus Prostate Specific Membrane Antigen , 1995 .
[34] M. Stampfer,et al. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. , 1995, JAMA.
[35] T. Wheeler,et al. Fresh tissue harvest for research from prostatectomy specimens , 1994, The Prostate.
[36] M. Benson,et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. , 1994, Urology.
[37] T. Wheeler,et al. Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer. , 1994, The Journal of urology.
[38] T. Stamey,et al. Observations on the doubling time of prostate cancer. The use of serial prostate‐specific antigen in patients with untreated disease as a measure of increasing cancer volume , 1993, Cancer.
[39] D. Tindall,et al. Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. , 1992, Biochemistry.
[40] P. Scardino,et al. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. , 1991, The Journal of urology.
[41] P. Riegman,et al. Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species , 1991, Molecular and Cellular Endocrinology.
[42] B. Morris,et al. Primary structure of a human glandular kallikrein gene. , 1987, DNA.
[43] G. Murphy,et al. Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction. , 2000, Seminars in surgical oncology.
[44] C. Olsson,et al. The role of reverse transcriptase-polymerase chain reaction for staging patients with clinically localized prostate cancer. , 1998, Seminars in Urologic Oncology.
[45] M. Benson,et al. Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. , 1995, The Journal of urology.
[46] E. Diamandis,et al. Prostate‐Specific antigen expression by various tumors , 1995, Journal of clinical laboratory analysis.